Clinical trials recruiting for Neurodegenerative Diseases
23
Recruiting trials
6
US states with sites
18
Countries
39%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Not applicable 22
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Lipopolysaccharide | 1 |
| PET/MR with [11C]PBR28 | 1 |
| Probiotic Blend Capsule | 1 |
| Stool samples | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Connecticut | 1 |
| Florida | 1 |
| Massachusetts | 1 |
| New York | 1 |
| North Carolina | 1 |
| Texas | 1 |
Top cities
Austin, Texas 1Belmont, Massachusetts 1Coral Springs, Florida 1Durham, North Carolina 1Rochester, New York 1Westport, Connecticut 1
Self-screener
Recruiting trials
- Beta Amyloid PET/CT in Various Aβ-Related Disease
- Blood And Tears in Alzheimer's Disease
- Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
- Longitudinal Investigation of I2BS in PD
- Memory Deterioration in Alzheimer Disease
- Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR
- Molecular and Functional Imaging in Monogenic PD.
- Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
- Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
- Neurologic Stem Cell Treatment Study
- New CSF Biomarkers for Alzheimer's Disease
- Observational Pharmaco-Epidemiology Research & Analysis
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- Probiotics in Mild Alzheimer's Disease
- Retinal Hyperspectral Imaging in Neurodegenerative Diseases
- Saliva and Extracellular Vesicles for Neurodegenerative Diseases
- Serotonin Release in Premotor and Motor PD
- Shanghai At Risk for Alzheimer's Disease: a Cohort Study
- Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
- Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
- Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
- Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Related conditions
Trials recruiting for Neurodegenerative Diseases often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Parkinson's disease 522Dementia 106Nervous System Diseases 11Synucleinopathies 8Neurocognitive Disorders 11Central Nervous System Diseases 9Brain Diseases 15Prodromal Stage 3Parkinsonian Disorders 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Neurodegenerative Diseases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.